REGISTRATION NOW OPEN! Seating is limited, RSVP NOW!

Session I:
“Redefining Early Pancreatic Cancer—Detection and Interception”

Moderated by David Tuveson, MD, PhD, Director of the Cold Spring Harbor Laboratory Cancer Center and Lustgarten Chief Scientist, this session will feature four renowned scientists presenting their latest research on risk assessment, detection & surveillance, and interception of early-stage pancreatic cancer.

The panel Q&A discussion will ask us to broaden our perspectives and delve deeper into the complex challenges and opportunities inherent in developing effective strategies for early detection and interception of this deadly disease.

 

Session I: Speakers

IMPROVING RISK ASSESSMENT

Brian M. Wolpin, MD, PhD
Dana-Farber Cancer Institute

DETECTION AND SURVEILLANCE

Marcia (Mimi) Canto, MD, MHS
The Johns Hopkins University School of Medicine

 
 

Anne Marie Lennon, MBBCh, PhD
The Johns Hopkins University School of Medicine

TOWARD INTERCEPTION

Peter J. Allen, MD
Duke University School of Medicine